Host: |
Rabbit |
Applications: |
WB |
Reactivity: |
Mouse/Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-ZNF645 (346-425) is suitable for use in Western Blot research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3. |
Purification: |
Affinity purification |
Dilution Range: |
WB 1:500-1:2000 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
CBLL2 |
Gene ID: |
158506 |
Uniprot ID: |
CBLL2_HUMAN |
Immunogen Region: |
346-425 |
Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 346-425 of human ZNF645 (NP_689790.1). |
Immunogen Sequence: |
QNGNPSASEFASHHYNLNIL PQFTENQETLSPQFTQTDAM DHRRWPAWKRLSPCPPTRSP PPSTLHGRSHHSHQRRHRRY |
Tissue Specificity | Exclusively expressed in testis and sperm, including spermatocytes, round and elongated spermatids, and Leydig cells. |
Function | E3 ubiquitin ligase catalyzing the covalent attachment of ubiquitin moieties onto substrate proteins. May operate on tyrosine-phosphorylated SRC substrates. |
Protein Name | E3 Ubiquitin-Protein Ligase Cbll2Cbl Proto-Oncogene-Like Protein 2Ring-Type E3 Ubiquitin Transferase Znf645Zinc Finger Protein 645C-Cbl-Like Protein 2 |
Database Links | Reactome: R-HSA-983168 |
Cellular Localisation | CytoplasmLocalized Over The Postacrosomal Perinuclear Theca Region And The Entire Length Of Sperm Tail |
Alternative Antibody Names | Anti-E3 Ubiquitin-Protein Ligase Cbll2 antibodyAnti-Cbl Proto-Oncogene-Like Protein 2 antibodyAnti-Ring-Type E3 Ubiquitin Transferase Znf645 antibodyAnti-Zinc Finger Protein 645 antibodyAnti-C-Cbl-Like Protein 2 antibodyAnti-CBLL2 antibodyAnti-ZNF645 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance